Elliott S J, Salcedo J R
Urology. 1985 Jul;26(1):20-1. doi: 10.1016/0090-4295(85)90247-x.
Aminocaproic acid (EACA) was used in 2 patients with cadaveric renal allografts because gross hematuria developed after percutaneous renal biopsies. Marked improvement was noted within twelve hours with no recurrence after discontinuation of EACA. EACA was effective in moderate renal failure.
氨基己酸(EACA)用于2例尸体肾移植患者,因为在经皮肾活检后出现了肉眼血尿。12小时内可见明显改善,停用EACA后未复发。EACA对中度肾衰竭有效。